K901972

Substantially Equivalent

ADD'L CLAIMED INTENDED USE FOR IDEIA(TM) CHLAMYDIA

Applicant
Novo Nordisk Diagnostics, Ltd.
Product code
LJC
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Cambridge Cb4 4ws England, GB
Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.